Regarding subclinical atherosclerosis, our recent meta-analysis of 12 controlled studies found an increased overall IMT compared with matched controls, however, this was not evident in studies involving patients with low disease activity (mean BASDAI < 4) or in those studies that included >50% of patients treated with anti-TNF [23]. The gene discussed is TNF; the disease is atherosclerosis.